RE: Where is the bloody buyback24 Jul 2019 16:20
£1M is symbolic only of the board's confidence that the business has matured to a point of being cash generative. £1M is nearly 2% of the company's market cap, not an insignificant start to the program. Further, if the board and management are correct in assessing that legacy issues are fully in the past AND the recurring revenue nature of the model is taking hold, then buying back shares (at current levels) is a far better use of cash than a dividend. Additionally, the stock is not reacting because it's a micro-cap. It's too far below the radar of nearly any institutional buyer. IMO, there are three possible outcomes: 1. the company is sold to a consolidator or some competitor doing a tuck-in acquisition; 2. the stock slowly grinds higher over the next couple years as the company, being the primary buyer, methodically reduces the share count while still growing through losses and building retained earnings; 3. this ends up being a total fail because of an unforeseen occurrence - always a risk.